| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $87.1M | +6.2% |
| Cost of Revenue | $68.2M | +39.4% |
| Gross Profit | $19.0M | +2432.8% |
| R&D Expense | $13.9M | -16.0% |
| SG&A Expense | $5.1M | -2.8% |
| Operating Income | -$7.9M | -197.7% |
| Pre-tax Income | -$7.5M | -821.3% |
| Income Tax | -$565K | -765.9% |
| Net Income | -$7.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.7M | — |
| Short-term Investments | $0 | — |
| Accounts Receivable | $2.6M | -6.0% |
| Inventory | $131K | -84.2% |
| Current Assets | $55.2M | — |
| Total Assets | $72.1M | +55.0% |
| Current Liabilities | $4.8M | +928.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.0M | +361.3% |
| Capital Expenditures | $161K | +346.9% |
| Investing Cash Flow | $2.8M | +105.9% |
| Financing Cash Flow | -$2.4M | -105.1% |
| Free Cash Flow | $1.8M | +328.8% |
| -757.1% |
| Total Liabilities |
| $5.1M |
| +150.4% |
| Stockholders' Equity | $66.8M | +3475.0% |